Skip to main content
Table of Contents
Print

Are gene-editing clinical trials being planned for autism? 

Author: Lucia Alvarez, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Gene-editing clinical trials for autism are not yet underway in humans, but early-stage research is laying the groundwork for future testing. As scientists learn more about the genetic underpinnings of autism, particularly in rare, single-gene forms, there is growing interest in whether technologies like CRISPR could be applied as a targeted autism treatment. 

At present, most CRISPR-related studies in autism are being conducted in animal models or laboratory settings. These experiments focus on correcting specific mutations, such as those in the SHANK3 or MECP2 genes, to observe whether modifying genetic function can influence behaviour, social communication or neurological development. While no human gene-editing clinical trials for autism have begun, research is progressing rapidly. Clinical trials may become a possibility within the next decade, particularly for those with clear, monogenic diagnoses. 

What Needs to Happen Before Trials Begin? 

Here are two critical steps before CRISPR trials for autism could be launched: 

Prove safety and efficacy in preclinical models 

Researchers must first demonstrate that gene editing can safely and consistently improve symptoms in animals without causing harmful side effects. These findings are a prerequisite for any human testing. 

Address ethical and regulatory challenges 

Gene-editing, especially in the brain, raises complex ethical questions. Trials would require rigorous oversight to ensure informed consent, safety protocols and long-term monitoring of outcomes. 

The potential for future therapies using gene editing in autism is promising, especially for families affected by known genetic mutations. Visit providers like Autism Detect for personal consultations and further guidance on screening and support. 

For a deeper dive into the science, diagnosis and full treatment landscape, read our complete guide to Genetic Influences.

Lucia Alvarez, MSc
Author

Lucia Alvarez is a clinical psychologist with a Master’s in Clinical Psychology and extensive experience providing evidence-based therapy and psychological assessment to children, adolescents, and adults. Skilled in CBT, DBT, and other therapeutic interventions, she has worked in hospital, community, and residential care settings. Her expertise includes grief counseling, anxiety management, and resilience-building, with a strong focus on creating safe, supportive environments to improve mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories